Featured RQSHA publication

Impact of Depressive Symptom Severity on Buprenorphine/Naloxone and Methadone Outcomes in People With Prescription-Type Opioid Use Disorder: Results From a Pragmatic Randomized Controlled Trial

Posted on 2024-04-16 by Vincent Bordeleau

The authors present a pragmatic randomized controlled trial showing how ongoing depressive symptoms lead to poorer outcomes in prescription-type opioid use disorder (April 2024).

Read the article in Journal of Dual Diagnosis